Moum B, Høivik ML, Follin-Arbelet B, Vatn M(2026) The Inflammatory Bowel Disease in South-Eastern Norway study: three decades of advancements in clinical understanding and scientific partnerships Therap Adv Gastroenterol, 19, 17562848251413125 DOI 10.1177/17562848251413125, PubMed 41531802
Holten KIA, Bernklev T, Opheim R, Olsen BC, Johansen I, Strande V, Boyar R, Hovde Ø, Torp R, Bengtson MB, Aabrekk TB, Detlie TE, Frigstad SO, Kristensen VA, Hagen M, Henriksen M, Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP(2026) Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III study Dig Dis Sci(in press) DOI 10.1007/s10620-025-09661-0, PubMed 41526576
Mahdy AKH, ElAbd H, Kokubun ÉE, Kriukova V, Pesesky M, May DH, Olbjørn C, Perminow G, Bengtson MB, Ricanek P, Andersen S, Detlie TE, Kristensen VA, Moum B, Vatn MH, Jahnsen J, Bokemeyer B, Hov JR, Halfvarson J, Schreiber S, Howie B, Robins HS, Høivik ML, Franke A, IBSEN-III study group(2026) Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages Genome Med, 18(1), 3 DOI 10.1186/s13073-025-01575-w, PubMed 41514338